Organogenesis Holdings Inc.
ORGONASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 26, 2026 close
- Market cap
- $120.36M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.93$7.08
- Volume (live)
- -
- Avg. volume (3M)
- 765.55K
Organogenesis Holdings (ORGO) Stock Price & Financial Analysis
Organogenesis Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.93 - $1.01 |
|---|---|
| 52-Week High | $7.08 |
| 52-Week Low | $0.93 |
| Open | $0.99 |
| Volume (last close) | 698.27K |
| Average Volume (3M) | 765.55K |
| Revenue (TTM) | 456.92M |
|---|---|
| Net Income (TTM) | -94.20M |
| Free Cash Flow (TTM) | 20.84M |
| EPS (TTM) | −$0.73 |
| Profit Margin | -20.62% |
| Operating Margin | -6.84% |
| Return on Equity (ROE) | -32.69% |
| Debt to Equity | 0.23 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 120.36M |
|---|---|
| Shares Outstanding | 128.67M |
| Price to Sales (P/S) | 0.26 |
| Price to Book (P/B) | 0.42 |
| EV/EBITDA | -22.80 |
| 50-Day MA | $1.50 |
|---|---|
| 200-Day MA | $2.50 |
| 1-Year Change | −74.94% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Organogenesis Holdings at a Glance
As of the Oct 26, 2026 close, Organogenesis Holdings (ORGO) has a market capitalization of $120.36M. The stock trades at 0.3× sales. Over the trailing twelve months it lost $94.20M on revenue of $456.92M and generated $20.84M of free cash flow. Revenue grew 6.3% year over year.
As of its latest reported balance sheet, it holds $46.10M in cash and securities against $66.95M of debt, a net debt position of $20.85M.
Organogenesis Holdings does not currently pay a dividend.
The share price is down 74.9% over the past year. At $0.94 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $0.93 to $7.08, below its 200-day moving average of $2.50.
Frequently Asked Questions About Organogenesis Holdings
What is the current stock price for ORGO?
As of the Oct 26, 2026 close, ORGO stock trades at $0.94. The 52-week range is $0.93–$7.08, with a day range of $0.93–$1.01.
What is the P/E ratio for ORGO?
The P/E ratio (Price-to-Earnings) for ORGO is shown in the Key Statistics section. This valuation metric helps compare Organogenesis Holdings Inc. to industry peers.
Does ORGO pay dividends?
Organogenesis Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ORGO?
Analyst ratings and recommendations for ORGO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ORGO?
As of the Oct 26, 2026 close, Organogenesis Holdings's market capitalization is $120.4M, classifying it as a micro-cap company. Organogenesis Holdings operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.